ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Since adiponectin and leptin exert antagonistic effects on liver fibrogenesis and inflammation, the ratio of adiponectin to leptin might be a better marker with which to distinguish NASH from NAFLD.